Abstract
Cardiac disease is a leading cause of death worldwide. Disturbance in the conduction system of the heart may trigger or aggravate heart dysfunction, affecting the efficiency of the heart, and lead to heart failure or cardiac arrest. Patients may require implantable cardiac rhythm management devices (ICRMDs) to maintain or restore the heart rhythm. ICRMDs have undergone important improvements, yet limitations still exist, presenting important technological challenges. Most ICRMDs consist of a subcutaneous control unit and intracardiac electrodes. The leads, which connect the electrodes to the control unit, are usually placed transvenously through the subclavian veins. Various locations inside the heart are used for placement of electrodes, depending on the specific condition. Some of the limitations to effective pacemaker therapy are associated with placement and location of the leads. Various approaches have been developed to overcome these challenges, such as multi-site pacing and leadless solutions. This paper aims to review the state of the art for the selection of placement sites for pacemakers, implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy devices (CRT) devices and discuss potential technological advancements to improve the results of ICRMD-therapy including development av leadless technology.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10439-019-02376-0/MediaObjects/10439_2019_2376_Fig1_HTML.png)
[The heart figure has been modified and reprinted with permission of Pearson Education, Inc., New York, New York116]. [The images of the devices shown in all figures (Platinium™) are trademark of LivaNova, London, UK].
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10439-019-02376-0/MediaObjects/10439_2019_2376_Fig2_HTML.png)
[The heart figure has been modified and reprinted with permission of Pearson Education, Inc., New York, New York116].
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10439-019-02376-0/MediaObjects/10439_2019_2376_Fig3_HTML.png)
[The heart figure has been modified and reprinted with permission of Pearson Education, Inc., New York, New York116].
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10439-019-02376-0/MediaObjects/10439_2019_2376_Fig4_HTML.png)
[The heart figure has been modified and reprinted with permission of Pearson Education, Inc., New York, New York116].
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10439-019-02376-0/MediaObjects/10439_2019_2376_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10439-019-02376-0/MediaObjects/10439_2019_2376_Fig6_HTML.png)
[The heart figure has been modified and reprinted by permission of Pearson Education, Inc., New York, New York116].
Similar content being viewed by others
References
Abella, B. and D. Edelson. Resuscitation errors: a shocking problem. WebM&M: Morbidity & Mortality Rounds on the Web. Rockville, MD: Agency for Healthcare Research and Quality, 2007.
Abkenari, L. D., D. A. Theuns, S. D. Valk, Y. Van Belle, N. M. de Groot, D. Haitsma, A. Muskens-Heemskerk, T. Szili-Torok, and L. Jordaens. Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin. Res. Cardiol. 100:737–744, 2011.
Abraham, W. T., W. G. Fisher, A. L. Smith, D. B. Delurgio, A. R. Leon, E. Loh, D. Z. Kocovic, M. Packer, A. L. Clavell, and D. L. Hayes. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med. 346:1845–1853, 2002.
Albatat, M., D. R. King, L. A. Unger, H. Arevalo, S. Wall, J. Sundnes, J. Bergsland, and I. Balasingham. Electromechanical model to predict cardiac resynchronization therapy. Conf. Proc. IEEE Eng. Med. Biol. Soc. 5446–5459:2018, 2018.
Albouaini, K., A. Alkarmi, T. Mudawi, M. D. Gammage, and D. J. Wright. Selective site right ventricular pacing. Heart 95:2030–2039, 2009.
Alonso, C., C. Leclercq, F. Victor, H. Mansour, C. de Place, D. Pavin, F. Carré, P. Mabo, and J. C. Daubert. Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. Am. J. Cardiol. 84:1417–1421, 1999.
Ansalone, G., P. Giannantoni, R. Ricci, P. Trambaiolo, F. Fedele, and M. Santini. Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J. Am. Coll. Cardiol. 39:489–499, 2002.
Antoniadis, A. P., B. Sieniewicz, J. Gould, B. Porter, J. Webb, S. Claridge, J. M. Behar, and C. A. Rinaldi. Updates in cardiac resynchronization therapy for chronic heart failure: review of multisite pacing. Curr. Heart Fail. Rep. 14:376–383, 2017.
Aoukar, P. S., J. E. Poole, G. W. Johnson, R. J. Anderson, A. S. Hellkamp, D. B. Mark, K. L. Lee, and G. H. Bardy. No benefit of a dual coil over a single coil ICD lead: evidence from the sudden cardiac death in heart failure trial. Heart Rhythm 10:970–976, 2013.
Arevalo, H. J., F. Vadakkumpadan, E. Guallar, A. Jebb, P. Malamas, K. C. Wu, and N. A. Trayanova. Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models. Nat. Commun. 7:11437, 2016.
Auricchio, A., P.-P. Delnoy, F. Regoli, M. Seifert, T. Markou, C. Butter, and C. S. Group. First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients. Europace 15:1191–1197, 2013.
Auricchio, A., C. Fantoni, F. Regoli, C. Carbucicchio, A. Goette, C. Geller, M. Kloss, and H. Klein. Characterization of left ventricular activation in patients with heart failure and left bundle-branch block. Circulation 109:1133–1139, 2004.
Auricchio, A., H. Klein, B. Tockman, S. Sack, C. Stellbrink, J. Neuzner, A. Kramer, J. Ding, T. Pochet, and A. Maarse. Transvenous biventricular pacing for heart failure: can the obstacles be overcome? Am. J. Cardiol. 83:136–142, 1999.
Auricchio, A., and F. W. Prinzen. Non-responders to cardiac resynchronization therapy. Circ. J. 75:521–527, 2011.
Auricchio, A., C. Stellbrink, M. Block, S. Sack, J. Vogt, P. Bakker, H. Klein, A. Kramer, J. Ding, and R. Salo. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 99:2993–3001, 1999.
Auricchio, A., C. Stellbrink, C. Butter, S. Sack, J. Vogt, A. R. Misier, D. Böcker, M. Block, J. H. Kirkels, and A. Kramer. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J. Am. Coll. Cardiol. 42:2109–2116, 2003.
Auricchio, A., C. Stellbrink, S. Sack, M. Block, J. ürgen Vogt, P. Bakker, C. Huth, F. Schöndube, U. Wolfhard, and D. Böcker. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J. Am. Coll. Cardiol. 39:2026–2033, 2002.
Awan, M., S. Perez-Simbor, C. Garcia-Pardo, K. Kansanen, and N. Cardona. Experimental phantom-based security analysis for next-generation leadless cardiac pacemakers. Sensors 18:4327, 2018.
Bailin, S. J., S. Adler, and M. Giudici. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann’s bundle: results of a multicenter randomized trial. J. Cardiovasc. Electrophysiol. 12:912–917, 2001.
Bakker, P. F., H. W. Meijburg, J. W. de Vries, M. M. Mower, A. C. Thomas, M. L. Hull, E. O. R. de Medina, and J. J. Bredée. Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function. J. Interv. Cardiac Electrophysiol. 4:395–404, 2000.
Bardy, G. H., G. L. Dolack, P. J. Kudenchuk, J. E. Poole, R. Mehra, and G. Johnson. Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode. Circulation 89:1090–1093, 1994.
Bardy, G. H., W. M. Smith, M. A. Hood, I. G. Crozier, I. C. Melton, L. Jordaens, D. Theuns, R. E. Park, D. J. Wright, and D. T. Connelly. An entirely subcutaneous implantable cardioverter–defibrillator. N. Engl. J. Med. 363:36–44, 2010.
Batra, A. S., and S. Balaji. Post operative temporary epicardial pacing: when, how and why? Ann. Pediatric Cardiol. 1:120, 2008.
Bernstein, A. D., J. C. Daubert, R. D. Fletcher, D. L. Hayes, B. Lüderitz, D. W. Reynolds, M. H. Schoenfeld, and R. Sutton. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. Pacing Clin. Electrophysiol. 25:260–264, 2002.
Biffi, M., C. Moschini, M. Bertini, D. Saporito, M. Ziacchi, I. Diemberger, C. Valzania, G. Domenichini, E. Cervi, and C. Martignani. Phrenic stimulation. Circ.: Arrhythm. Electrophysiol. 2:402–410, 2009.
Blanc, J.-J., V. Bertault-Valls, M. Fatemi, M. Gilard, P.-Y. Pennec, and Y. Etienne. Midterm benefits of left univentricular pacing in patients with congestive heart failure. Circulation 109:1741–1744, 2004.
Bleeker, G. B., T. A. Kaandorp, H. J. Lamb, E. Boersma, P. Steendijk, A. de Roos, E. E. van der Wall, M. J. Schalij, and J. J. Bax. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 113:969–976, 2006.
Boink, G. J., L. Duan, B. D. Nearing, I. N. Shlapakova, E. A. Sosunov, E. P. Anyukhovsky, E. Bobkov, Y. Kryukova, N. Ozgen, and P. Danilo. HCN2/SkM1 gene transfer into canine left bundle branch induces stable, autonomically responsive biological pacing at physiological heart rates. J. Am. Coll. Cardiol. 61:1192–1201, 2013.
Bordachar, P., N. Derval, S. Ploux, S. Garrigue, P. Ritter, M. Haissaguerre, and P. Jaïs. Left ventricular endocardial stimulation for severe heart failure. J. Am. Coll. Cardiol. 56:747–753, 2010.
Bose, P., A. Khaleghi, M. Albatat, J. Bergsland, and I. Balasingham. RF channel modeling for implant-to-implant communication and implant to subcutaneous implant communication for future leadless cardiac pacemakers. IEEE Trans. Biomed. Eng. 65:2798–2807, 2018.
Bose P., A. Khaleghi and I. Balasingham. Wireless channel modeling for leadless cardiac pacemaker: effects of ventricular blood volume. In: 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) IEEE, 2018, pp. 3746–3749.
Brandt, N. H., R. E. Kirkfeldt, J. C. Nielsen, L. S. Mortensen, G. V. H. Jensen, J. B. Johansen, and K. Haugan. Single lead atrial vs. dual chamber pacing in sick sinus syndrome: extended register-based follow-up in the DANPACE trial. EP Europace 19:1981–1987, 2016.
Brignole, M., A. Auricchio, G. Baron-Esquivias, P. Bordachar, G. Boriani, O.-A. Breithardt, J. Cleland, J.-C. Deharo, V. Delgado, and P. M. Elliott. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Revista española de cardiología-English Edition 67:58e51–58e60, 2014.
Bristow, M. Comparison of medical resynchronization and defibrillation therapies in heart failure (COMPANION) trial. Bethesda: American College of Cardiology, 2003.
Brunner, M. P., E. M. Cronin, O. Wazni, B. Baranowski, W. I. Saliba, J. F. Sabik, B. D. Lindsay, B. L. Wilkoff, and K. G. Tarakji. Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction. Heart Rhythm 11:419–425, 2014.
Burke, M. C., M. R. Gold, B. P. Knight, C. S. Barr, D. A. Theuns, L. V. Boersma, R. E. Knops, R. Weiss, A. R. Leon, and J. M. Herre. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE Study and EFFORTLESS Registry. J. Am. Coll. Cardiol. 65:1605–1615, 2015.
Butter, C., A. Auricchio, C. Stellbrink, E. Fleck, J. Ding, Y. Yu, E. Huvelle, and J. Spinelli. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 104:3026–3029, 2001.
Butter, C., A. Auricchio, C. Stellbrink, M. Schlegl, E. Fleck, W. Hörsch, E. Huvelle, J. Ding, A. Kramer, and P. T. I. C. H. F. I. S. Group. Should stimulation site be tailored in the individual heart failure patient? Am. J. Cardiol. 86:K144–K151, 2000.
Cappato, R., S. Castelvecchio, P. Erlinger, R. Sanghera, D. Scheck, A. Ostroff, W. Rissmann, C. Gropper, and G. H. Bardy. Feasibility of defibrillation and automatic arrhythmia detection using an exclusively subcutaneous defibrillator system in canines. J. Cardiovasc. Electrophysiol. 24:77–82, 2013.
Cazeau, S., P. Ritter, S. Bakdach, A. Lazarus, M. Limousin, L. Henao, O. Mundler, J. Daubert, and J. Mugica. Four chamber pacing in dilated cardiomyopathy. Pacing Clin. Electrophysiol. 17:1974–1979, 1994.
Chalil, S., B. Stegemann, S. Muhyaldeen, K. Khadjooi, P. Foley, R. Smith, and F. Leyva. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Pacing Clin. Electrophysiol. 30:1201–1209, 2007.
Chung, E. S., A. R. Leon, L. Tavazzi, J.-P. Sun, P. Nihoyannopoulos, J. Merlino, W. T. Abraham, S. Ghio, C. Leclercq, and J. J. Bax. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117:2608–2616, 2008.
Cicchitti, V., F. Radico, F. Bianco, S. Gallina, G. Tonti, and R. De Caterina. Heart failure due to right ventricular apical pacing: the importance of flow patterns. EP Europace 18:1679–1688, 2016.
Cleland, J. G., J.-C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, and L. Tavazzi. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med. 352:1539–1549, 2005.
Dallonnes, G. R., D. Pavin, C. Leclercq, J. E. Ecke, G. Jauvert, P. Mabo, and J. C. Daubert. Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia a nine-year experience. J. Cardiovasc. Electrophysiol. 11:1081–1091, 2000.
Daoud, E. G., S. J. Kalbfleisch, J. D. Hummel, R. Weiss, R. S. Augustini, S. B. Duff, G. Polsinelli, J. Castor, and T. Meta. Implantation techniques and chronic lead parameters of biventricular pacing dual-chamber defibrillators. J. Cardiovasc. Electrophysiol. 13:964–970, 2002.
Daubert, J.-C., D. Pavin, G. Jauvert, and P. Mabo. Intra-and interatrial conduction delay: implications for cardiac pacing. Pacing Clin. Electrophysiol. 27:507–525, 2004.
Daubert, J. P., W. Zareba, D. S. Cannom, S. McNitt, S. Z. Rosero, P. Wang, C. Schuger, J. S. Steinberg, S. L. Higgins, and D. J. Wilber. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J. Am. Coll. Cardiol. 51:1357–1365, 2008.
De Maria, E., D. Giacopelli, A. Borghi, L. Modonesi, and S. Cappelli. Antitachycardia pacing programming in implantable cardioverter defibrillator: a systematic review. World J. Cardiol. 9:429, 2017.
De Maria, E., A. Olaru, and S. Cappelli. The entirely subcutaneous defibrillator (S-ICD): state of the art and selection of the ideal candidate. Curr. Cardiol. Rev. 11:180–186, 2015.
Dekker, A., B. Phelps, B. Dijkman, T. van Der Nagel, F. van Der Veen, G. Geskes, and J. Maessen. Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loops. J. Thorac. Cardiovasc. Surg. 127:1641–1647, 2004.
Delfaut, P., S. Saksena, A. Prakash, and R. B. Krol. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single-and dual-site right atrial pacing for arrhythmia prevention. J. Am. Coll. Cardiol. 32:1900–1908, 1998.
Delgado, V., R. J. van Bommel, M. Bertini, C. J. W. Borleffs, N. A. Marsan, A. C. Ng, G. Nucifora, N. R. van de Veire, C. Ypenburg, and E. Boersma. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapyclinical perspective. Circulation 123:70–78, 2011.
Derval, N., P. Steendijk, L. J. Gula, A. Deplagne, J. Laborderie, F. Sacher, S. Knecht, M. Wright, I. Nault, and S. Ploux. Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J. Am. Coll. Cardiol. 55:566–575, 2010.
Deshmukh, P., D. A. Casavant, M. Romanyshyn, and K. Anderson. Permanent, direct his-bundle pacing a novel approach to cardiac pacing in patients with normal his-Purkinje activation. Circulation 101:869–877, 2000.
Deshmukh, P. M., and M. Romanyshyn. Direct his-bundle pacing. Pacing Clin. Electrophysiol. 27:862–870, 2004.
Echt, D. S., M. W. Cowan, R. E. Riley, and A. F. Brisken. Feasibility and safety of a novel technology for pacing without leads. Heart Rhythm 3:1202–1206, 2006.
Echt, D., D. Moore, M. Cowan, V. Valli, J. Whitehair, and N. Willis. Chronic implantation of leadless pacing electrodes in the left ventricle of a goat model. Heart Rhythm 7:S451–452, 2010.
El Gamal, M. Atrial pacing, the forgotten pacing mode. Netherl. Heart J. 16:23–26, 2008.
Europace. Cardiovascular Diseases Statistics. http://ec.europa.eu/eurostat/statistics-explained/index.php/Cardiovascular_diseases_statistics#Further_Eurostat_information. Accessed 15 Jan 2017.
Ezekowitz, J. A., P. W. Armstrong, and F. A. McAlister. Implantable cardioverter defibrillators in primary and secondary prevention a systematic review of randomized, controlled trials. Ann. Intern. Med. 138:445–452, 2003.
Fishman, G. I., S. S. Chugh, J. P. DiMarco, C. M. Albert, M. E. Anderson, R. O. Bonow, A. E. Buxton, P.-S. Chen, M. Estes, and X. Jouven. Sudden cardiac death prediction and prevention: report from a National Heart, lung, and blood institute and heart rhythm society workshop. Circulation 122:2335–2348, 2010.
Foley, P. W., S. Chalil, K. Ratib, R. Smith, F. Prinzen, A. Auricchio, and F. Leyva. Fluoroscopic left ventricular lead position and the long-term clinical outcome of cardiac resynchronization therapy. Pacing Clin. Electrophysiol. 34:785–797, 2011.
Frias, P. A., J. S. Corvera, L. Schmarkey, M. Strieper, R. M. Campbell, and J. Vinten-Johansen. Evaluation of myocardial performance with conventional single-site ventricular pacing and biventricular pacing in a canine model of atrioventricular block. J. Cardiovasc. Electrophysiol. 14:996–1000, 2003.
Fung, J. W., J. Y. Chan, G. W. Yip, H. C. Chan, W. W. Chan, Q. Zhang, and C.-M. Yu. Effect of left ventricular endocardial activation pattern on echocardiographic and clinical response to cardiac resynchronization therapy. Heart 93:432–437, 2007.
Fung, J. W., C. Yu, G. Yip, Y. Zhang, H. Chan, C. Kum, and J. Sanderson. Variable left ventricular activation pattern in patients with heart failure and left bundle branch block. Heart 90:17–19, 2004.
Garrigue, S., P. Jaïs, G. Espil, J.-N. Labeque, M. Hocini, D. C. Shah, M. Haïssaguerre, and J. Clementy. Comparison of chronic biventricular pacing between epicardial and endocardial left ventricular stimulation using Doppler tissue imaging in patients with heart failure. Am. J. Cardiol. 88:858–862, 2001.
Gasparini, M., M. Mantica, P. Galimberti, M. Bocciolone, L. Genovese, M. Mangiavacchi, U. La Marchesina, F. Faletra, C. Klersy, and R. Coates. Is the left ventricular lateral wall the best lead implantation site for cardiac resynchronization therapy? Pacing Clin. Electrophysiol. 26:162–168, 2003.
Gillis, A. M., A. M. Russo, K. A. Ellenbogen, C. D. Swerdlow, B. Olshansky, S. M. Al-Khatib, J. F. Beshai, J. M. McComb, J. C. Nielsen, and J. M. Philpott. HRS/ACCF expert consensus statement on pacemaker device and mode selection. J. Am. Coll. Cardiol. 60:682–703, 2012.
Ginks, M. R., P. D. Lambiase, S. G. Duckett, J. Bostock, P. Chinchapatnam, K. Rhode, M. J. McPhail, M. Simon, C. Bucknall, and G. Carr-White. A simultaneous X-ray/MRI and noncontact map** study of the acute hemodynamic effect of left ventricular endocardial and epicardial cardiac resynchronization therapy in humans clinical perspective. Circ.: Heart Fail. 4:170–179, 2011.
Ginks, M. R., A. K. Shetty, P. D. Lambiase, S. G. Duckett, J. Bostock, J. L. Peacock, K. S. Rhode, C. Bucknall, J. Gill, and P. Taggart. Benefits of endocardial and multisite pacing are dependent on the type of left ventricular electric activation pattern and presence of ischemic heart disease insights from electroanatomic map**. Circ.: Arrhythm. Electrophysiol. 5:889–897, 2012.
Gold, M. R., M. R. Olsovsky, M. A. Pelini, R. W. Peters, and S. R. Shorofsky. Comparison of single-and dual-coil active pectoral defibrillation lead systems. J. Am. Coll. Cardiol. 31:1391–1394, 1998.
Gold, M. R., and S. R. Shorofsky. Transvenous defibrillation lead systems. J. Cardiovasc. Electrophysiol. 7:570–580, 1996.
Gold, M. R., D. A. Theuns, B. P. Knight, J. Sturdivant, R. Sanghera, K. A. Ellenbogen, M. A. Wood, and M. C. Burke. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J. Cardiovasc. Electrophysiol. 23:359–366, 2012.
Goto, H., T. Sugiura, Y. Harada, and T. Kazui. Feasibility of using the automatic generating system for quartz watches as a leadless pacemaker power source. Med. Biol. Eng. Comput. 37:377–380, 1999.
Hammill, S. C., D. L. Packer, M. S. Stanton, and J. Fetter. Termination and acceleration of ventricular tachycardia with autodecremental pacing, burst pacing, and cardioversion in patients with an implantable cardioverter defibrillator. Pacing Clin. Electrophysiol. 18:3–18, 1995.
Hauser, R. G. The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. J. Am. Coll. Cardiol. 45:2022–2025, 2005.
Hauser, R. G., D. L. Hayes, L. M. Kallinen, D. S. Cannom, A. E. Epstein, A. K. Almquist, S. L. Song, G. F. O. Tyers, S. C. Vlay, and M. Irwin. Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective multicenter study. Heart Rhythm 4:154–160, 2007.
Hauser, R. G., W. T. Katsiyiannis, C. C. Gornick, A. K. Almquist, and L. M. Kallinen. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter–defibrillator and pacemaker lead extraction. Europace 12:395–401, 2010.
Hu, Y.-F., J. F. Dawkins, H. C. Cho, E. Marbán, and E. Cingolani. Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block. Sci. Transl. Med. 6:245ra294, 2014.
Hu, Y., V. Gurev, J. Constantino, and N. Trayanova. Optimizing cardiac resynchronization therapy to minimize ATP consumption heterogeneity throughout the left ventricle: a simulation analysis using a canine heart failure model. Heart Rhythm 11:1063–1069, 2014.
Huikuri, H., A. Castellanos, R. Myerburg, B. Pitt, F. Zannad, and W. Remme. Sudden death duo to cardiac arrhythmias. N. Engl. J. Med. 346:946–947, 2002.
Huntjens, P. R., J. Walmsley, S. Ploux, P. Bordachar, F. W. Prinzen, T. Delhaas, and J. Lumens. Influence of left ventricular lead position relative to scar location on response to cardiac resynchronization therapy: a model study. Europace 16:iv62–iv68, 2014.
Izutani, H., K. J. Quan, L. A. Biblo and I. S. Gill. Biventricular pacing for congestive heart failure: early experience in surgical epicardial versus coronary sinus lead placement. Heart Surg Forum, 2002, pp. E1–E6.
Jackson, T., R. Lenarczyk, M. Sterlinski, A. Sokal, D. Francis, Z. Whinnett, F. Van Heuverswyn, M. Vanderheyden, J. Heynens, and B. Stegemann. Left ventricular scar and the acute hemodynamic effects of multivein and multipolar pacing in cardiac resynchronization. IJC Heart Vasculature 19:14–19, 2018.
Jais, P., H. Douard, D. C. Shah, S. Barold, J. L. Barat, and J. Clementy. Endocardial biventricular pacing. Pacing Clin. Electrophysiol. 21:2128–2131, 1998.
Jais, P., A. Takahashi, S. Garrigue, T. Yamane, M. Hocini, D. C. Shah, S. S. Barold, I. Deisenhofer, and M. H. A. J. Clémenty. Mid-term follow-up of endocardial biventricular pacing. Pacing Clin. Electrophysiol. 23:1744–1747, 2000.
Jensen, P. N., N. N. Gronroos, L. Y. Chen, A. R. Folsom, S. R. Heckbert, and A. Alonso. Incidence of and risk factors for sick sinus syndrome in the general population. J. Am. Coll. Cardiol. 64:531–538, 2014.
Kamphuis, H., J. De Leeuw, R. Derksen, R. Hauer, and J. Winnubst. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery. Europace 5:381–389, 2003.
Kansanen, K. Wirless in-body environment, 2017.
Karami, M. A., D. J. Bradley, and D. J. Inman. Vibration powered cardiac rhythm devices. Circulation 126:A15551–A15551, 2012.
Kaye, G. C., N. J. Linker, T. H. Marwick, L. Pollock, L. Graham, E. Pouliot, J. Poloniecki, and M. Gammage. Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the protect-pace study. Eur. Heart J. 36:856–862, 2015.
Khan, F. Z., M. S. Virdee, S. P. Fynn, and D. P. Dutka. Left ventricular lead placement in cardiac resynchronization therapy: where and how? Europace 11:554–561, 2009.
Khan, F. Z., M. S. Virdee, C. R. Palmer, P. J. Pugh, D. O’Halloran, M. Elsik, P. A. Read, D. Begley, S. P. Fynn, and D. P. Dutka. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J. Am. Coll. Cardiol. 59:1509–1518, 2012.
Kirkfeldt, R. E., J. B. Johansen, E. A. Nohr, O. D. Jørgensen, and J. C. Nielsen. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur. Heart J. 35:1186–1194, 2013.
Kirkfeldt, R. E., J. B. Johansen, E. A. Nohr, M. Moller, P. Arnsbo, and J. C. Nielsen. Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28,860 Danish patients. Heart Rhythm 8:1622–1628, 2011.
Kiviniemi, M. S., M. A. Pirnes, H. J. K. ErÄNen, R. V. J. Kettunen, and J. E. K. Hartikainen. Complications related to permanent pacemaker therapy. Pacing Clin. Electrophysiol. 22:711–720, 1999.
Kleemann, T., T. Becker, K. Doenges, M. Vater, J. Senges, S. Schneider, W. Saggau, U. Weisse, and K. Seidl. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of > 10 years. Circulation 115:2474–2480, 2007.
Klug, D., M. Balde, D. Pavin, F. Hidden-Lucet, J. Clementy, N. Sadoul, J. L. Rey, G. Lande, A. Lazarus, and J. Victor. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators. Circulation 116:1349–1355, 2007.
Kremers, M. S., S. C. Hammill, C. I. Berul, C. Koutras, J. S. Curtis, Y. Wang, J. Beachy, L. B. Meisnere, D. M. Conyers, and M. R. Reynolds. The national ICD registry report. Heart Rhythm 10:e59, 2013.
Laish-Farkash, A., S. Bruoha, V. Khalameizer, C. Yosefy, Y. Michowitz, M. Suleiman, and A. Katz. Multisite cardiac resynchronization therapy for traditional and non-traditional indications. J. Interv. Cardiac Electrophysiol. 51:143–152, 2018.
Lakkireddy, D., R. Knops, B. Atwater, P. Neuzil, J. Ip, E. Gonzalez, P. Friedman, P. Defaye, D. Exner, K. Aonuma, R. Doshi, J. Sperzel, and V. Reddy. A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker. Heart Rhythm 14:1756–1763, 2017.
Lambiase, P., A. Rinaldi, J. Hauck, M. Mobb, D. Elliott, J. Gill, and C. Bucknall. Areas of slow conduction in biventricular pacing. A non-contact left ventricular endocardial map** study. Heart 90:44–51, 2004.
Leclercq, C., S. Cazeau, H. Le Breton, P. Ritter, P. Mabo, D. Gras, D. Pavin, A. Lazarus, and J.-C. Daubert. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J. Am. Coll. Cardiol. 32:1825–1831, 1998.
Leclercq, C., F. Gadler, W. Kranig, S. Ellery, D. Gras, A. Lazarus, J. Clémenty, E. Boulogne, J.-C. Daubert, and T.-H. S. Group. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. J. Am. Coll. Cardiol. 51:1455–1462, 2008.
Leclercq, F., F.-X. Hager, J.-C. Macia, C.-J. Mariottini, J.-L. Pasquie, and R. Grolleau. Left ventricular lead insertion using a modified transseptal catheterization technique: a totally endocardial approach for permanent biventricular pacing in end-stage heart failure. Pacing Clin. Electrophysiol. 22:1570–1575, 1999.
Lee, A. W. C., C. M. Costa, M. Strocchi, C. A. Rinaldi, and S. A. Niederer. Computational modeling for cardiac resynchronization therapy. J. Cardiovasc. Transl. Res. 11:92–108, 2018.
Lenarczyk, R., O. Kowalski, B. Sredniawa, P. Pruszkowska-Skrzep, M. Mazurek, E. Jedrzejczyk-Patej, A. Woźniak, S. Pluta, J. Głowacki, and Z. Kalarus. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial. J. Cardiovasc. Electrophysiol. 23:1228–1236, 2012.
Levine, P. and C. Love. Pacemaker diagnostics and evaluation of pacing system malfunction. In: Clinical Cardiac Pacing and Defibrillation, edited by K. Ellenbogen, G. Kay, C. Lau and B. Wilkoff. Philadelphia: WB Saunders, 2000, pp. 827–875.
León, A. R., W. T. Abraham, A. B. Curtis, J. P. Daubert, W. G. Fisher, J. Gurley, D. L. Hayes, R. Lieberman, S. Petersen-Stejskal, and K. Wheelan. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J. Am. Coll. Cardiol. 46:2348–2356, 2005.
Lovelock, J. D., C. Cruz, M. H. Hoskins, P. Jones, M. F. El-Chami, M. S. Lloyd, A. Leon, D. B. DeLurgio, and J. J. Langberg. Generator replacement is associated with an increased rate of ICD lead alerts. Heart Rhythm 11:1785–1789, 2014.
Lown, B. Defibrillation and cardioversion. Cardiovasc. Res. 55:220–224, 2002.
Lu, P., M. Veletić, J. Bergsland and I. Balasingham. On the intracellular signaling of cardiomyocytes for energy efficient leadless pacemakers. In: Proceedings of the 5th ACM International Conference on Nanoscale Computing and Communication, ACM, 2018, p. 31.
Mair, H., J. Sachweh, B. Meuris, G. Nollert, M. Schmoeckel, A. Schuetz, B. Reichart, and S. Daebritz. Surgical epicardial left ventricular lead versus coronary sinus lead placement in biventricular pacing. Eur. J. Cardiothorac. Surg. 27:235–242, 2005.
Mair H., J.-L. Jansens, O. M. Lattouf, B. Reichart, and S. Dabritz. Epicardial lead implantation techniques for biventricular pacing via left lateral mini-thoracotomy, video-assisted thoracoscopy, and robotic approach. Heart. Surg. Forum. 6:412–417, 2003.
Marieb, E. N., and K. Hoehn. Human Anatomy & Physiology. London: Pearson Education, 2007.
Martin, D. O., B. Lemke, D. Birnie, H. Krum, K. L.-F. Lee, K. Aonuma, M. Gasparini, R. C. Starling, G. Milasinovic, and T. Rogers. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm 9:1807–1814, 2012.
McAnulty, J., B. Halperin, J. Kron, G. Larsen, M. Rait, R. Swenson, R. Floreck, C. Marchant, M. Hamlin, and G. Heywood. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N. Engl. J. Med. 337:1576–1583, 1997.
Mehta, P. A., A. K. Shetty, M. Squirrel, J. Bostock, and C. A. Rinaldi. Elimination of phrenic nerve stimulation occurring during CRT. J. Interv. Cardiac Electrophysiol. 33:43–49, 2012.
Members, A. T. F., M. Brignole, A. Auricchio, G. Baron-Esquivias, P. Bordachar, G. Boriani, O.-A. Breithardt, J. Cleland, J.-C. Deharo, and V. Delgado. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur. Heart J. 34:2281–2329, 2013.
Miller, M. A., P. Neuzil, S. R. Dukkipati, and V. Y. Reddy. Leadless cardiac pacemakers: back to the future. J. Am. Coll. Cardiol. 66:1179–1189, 2015.
Mills, R. W., R. N. Cornelussen, L. J. Mulligan, M. Strik, L. M. Rademakers, N. D. Skadsberg, A. van Hunnik, M. Kuiper, A. Lampert, and T. Delhaas. Left ventricular septal and left ventricular apical pacing chronically maintain cardiac contractile coordination, pump function and efficiency. Circ.: Arrhythmia Electrophysiol. 2:571–579, 2009.
Mirowski, M., P. R. Reid, M. M. Mower, L. Watkins, V. L. Gott, J. F. Schauble, A. Langer, M. Heilman, S. A. Kolenik, and R. E. Fischell. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N. Engl. J. Med. 303:322–324, 1980.
Molhoek, S. G., J. J. Bax, L. van Erven, M. Bootsma, E. Boersma, P. Steendijk, E. E. van der Wall, and M. J. Schalij. Effectiveness of resynchronization therapy in patients with end-stage heart failure. Am. J. Cardiol. 90:379–383, 2002.
Moss, A. J., W. J. Hall, D. S. Cannom, J. P. Daubert, S. L. Higgins, H. Klein, J. H. Levine, S. Saksena, A. L. Waldo, and D. Wilber. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N. Engl. J. Med. 335:1933–1940, 1996.
Murphy, R. T., G. Sigurdsson, S. Mulamalla, D. Agler, Z. B. Popovic, R. C. Starling, B. L. Wilkoff, J. D. Thomas, and R. A. Grimm. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Am. J. Cardiol. 97:1615–1621, 2006.
Nadurata, V., A. Hamer, and P. Kertes. Optimizing the site of the right ventricular lead in cardiac resynchronization devices. Heart Lung Circ. 13:S5, 2004.
Niederer, S. A., J. Lumens, and N. A. Trayanova. Computational models in cardiology. Nat. Rev. Cardiol. 2018. https://doi.org/10.1038/s41569-018-0104-y.
Niederer, S. A., A. Shetty, G. Plank, J. Bostock, R. Razavi, N. Smith, and C. Rinaldi. Biophysical modeling to simulate the response to multisite left ventricular stimulation using a quadripolar pacing lead. Pacing Clin. Electrophysiol. 35:204–214, 2012.
Nordkamp, L. R. O., A. A. Wilde, J. G. Tijssen, R. E. Knops, P. F. van Dessel, and J. R. de Groot. The ICD for primary prevention in patients with inherited cardiac diseases: indications, utilization and outcome. A comparison with secondary prevention. Circ. Arrhythmia Electrophysiol. 6:91–100, 2012.
Noro, M., X. Zhu, Y. Enomoto, Y. Oikawa, H. Tatsunami, R. Ishii, Y. Toyoda, M. Asami, N. Sahara, and T. Takagi. Decreased defibrillation threshold and minimized myocardial damage with left axilla implantable cardioverter defibrillator implantation. Circ. J. 80:878–886, 2016.
Ogano, M., Y.-K. Iwasaki, J. Tanabe, H. Takagi, T. Umemoto, M. Hayashi, Y. Miyauchi, and K. Mizuno. Antiarrhythmic effect of cardiac resynchronization therapy with triple-site biventricular stimulation. Europace 15:1491–1498, 2013.
Olde-Nordkamp, L. R., J. L. Warnaars, K. M. Kooiman, J. R. Groot, B. R. Rosenmoeller, A. A. Wilde, and R. E. Knops. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J. Cardiovasc. Electrophysiol. 25:494–499, 2014.
Padeletti, L., A. Colella, A. Michelucci, P. Pieragnoli, G. Ricciardi, M. C. Porciani, F. Tronconi, D. A. Hettrick, and S. Valsecchi. Dual-site left ventricular cardiac resynchronization therapy. Am. J. Cardiol. 102:1687–1692, 2008.
Padeletti, L., P. Pieragnoli, C. Ciapetti, A. Colella, N. Musilli, M. C. Porciani, R. Ricci, C. Pignalberi, M. Santini, and A. Puglisi. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am. Heart J. 142:1047–1055, 2001.
Pappone, C., S. Rosanio, G. Oreto, M. Tocchi, S. Gulletta, A. Salvati, C. Dicandia, V. Santinelli, P. Mazzone, and F. Veglia. Cardiac pacing in heart failure patients with left bundle branch block: impact of pacing site for optimizing left ventricular resynchronization. Ital. Heart. J. 1:464–469, 2000.
Pavia, S., and B. Wilkoff. The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. Curr. Opin. Cardiol. 16:66–71, 2001.
Petch, M. Who needs dual chamber pacing? BMJ 307:215, 1993.
Polewczyk, A., W. Jacheć, A. Tomaszewski, W. Brzozowski, M. Czajkowski, G. Opolski, M. Grabowski, M. Janion, and A. Kutarski. Lead-related infective endocarditis: factors influencing early and long-term survival in patients undergoing transvenous lead extraction. Heart Rhythm 14:43–49, 2017.
Poole, J. E., G. W. Johnson, A. S. Hellkamp, J. Anderson, D. J. Callans, M. H. Raitt, R. K. Reddy, F. E. Marchlinski, R. Yee, and T. Guarnieri. Prognostic importance of defibrillator shocks in patients with heart failure. N. Engl. J. Med. 359:1009–1017, 2008.
Prakash, A., S. Saksena, M. Hill, R. B. Krol, A. N. Munsif, I. Giorgberidze, P. Mathew, and R. Mehra. Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation. J. Am. Coll. Cardiol. 29:1007–1014, 1997.
Priori, S. G., C. Blomström-Lundqvist, A. Mazzanti, N. Blom, M. Borggrefe, J. Camm, P. M. Elliott, D. Fitzsimons, R. Hatala, and G. Hindricks. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace euv 319:2015, 2015.
Ramzan M., X. Fang, Q. Wang, N. Neumann and D. Plettemeier. Miniaturized planar implanted spiral antenna inside the heart muscle at MICS band for future leadless pacemakers. In: 2019 13th International Symposium on Medical Information and Communication Technology (ISMICT), IEEE, 2019, pp. 1–4.
Ray, S., M. Griffith, S. Jamieson, R. Bexton, and R. Gold. Impact of the recommendations of the british pacing and electrophysiology group on pacemaker prescription and on the immediate costs of pacing in the Northern Region. Br. Heart J. 68:531–534, 1992.
Reddy, V. Y., M. A. Miller, P. Neuzil, P. Søgaard, C. Butter, M. Seifert, P. P. Delnoy, L. van Erven, M. Schalji, and L. V. Boersma. Cardiac resynchronization therapy with wireless left ventricular endocardial pacing: the SELECT-LV study. J. Am. Coll. Cardiol. 69:2119–2129, 2017.
Riedlbauchová, L., R. Ĉihaák, J. Byteŝník, V. Vanĉura, P. Frídl, L. Hoŝkovaá, and J. Kautzner. Optimization of right ventricular lead position in cardiac resynchronisation therapy. Eur. J. Heart Fail. 8:609–614, 2006.
Rinaldi, C., R. D. Simon, P. Geelen, S. Reek, A. Baszko, M. Kuehl, and J. S. Gill. A randomized prospective study of single coil versus dual coil defibrillation in patients with ventricular arrhythmias undergoing implantable cardioverter defibrillator therapy. Pacing Clin. Electrophysiol. 26:1684–1690, 2003.
Rizzo G., V. Loyau, R. Nocua, J. C. Lourme and E. Lefeuvre. Potentiality of magnetoelectric composites for wireless power transmission in medical implants. In: 2019 13th International Symposium on Medical Information and Communication Technology (ISMICT), IEEE, 2019, pp. 1–4.
Rodriguez, L., C. Timmermans, A. Nabar, G. Beatty, and H. J. Wellens. Variable patterns of septal activation in patients with left bundle branch block and heart failure. J. Cardiovasc. Electrophysiol. 14:135–141, 2003.
Rosen, M. R., R. B. Robinson, P. R. Brink, and I. S. Cohen. The road to biological pacing. Nat. Rev. Cardiol. 8:656–666, 2011.
Savarese, G., and L. H. Lund. Global public health burden of heart failure. Cardiac Fail. Rev. 3:7, 2017.
Saxon, L. A., D. L. Hayes, F. R. Gilliam, P. A. Heidenreich, J. Day, M. Seth, T. E. Meyer, P. W. Jones, and J. P. Boehmer. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up The ALTITUDE survival study. Circulation 122:2359–2367, 2010.
Saxon, L. A., B. Olshansky, K. Volosin, J. S. Steinberg, B. K. Lee, G. Tomassoni, T. Guarnieri, A. Rao, P. Yong, and E. Galle. Influence of left ventricular lead location on outcomes in the COMPANION study. J. Cardiovasc. Electrophysiol. 20:764–768, 2009.
Schulte, B., J. Sperzel, J. Carlsson, T. Schwarz, W. Ehrlich, H. Pitschner, and J. Neuzner. Dual-coil vs single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements. Europace 3:177–180, 2001.
Scientific, B. CRM product performance report. 2016. www.Bostonscientific.com. Accessed Aug 2016.
Scientific B. EMBLEM™ MRI S-ICD system. Implant procedures. 2017.
Sermesant, M., R. Chabiniok, P. Chinchapatnam, T. Mansi, F. Billet, P. Moireau, J.-M. Peyrat, K. Wong, J. Relan, and K. Rhode. Patient-specific electromechanical models of the heart for the prediction of pacing acute effects in CRT: a preliminary clinical validation. Med. Image Anal. 16:201–215, 2012.
Shepard, R. K., and K. A. Ellenbogen. Challenges and solutions for difficult implantations of CRT devices: the role of new technology and techniques. J. Cardiovasc. Electrophysiol. 18:S21–S25, 2007.
Shimony, A., M. J. Eisenberg, K. B. Filion, and G. Amit. Beneficial effects of right ventricular non-apical vs. apical pacing: a systematic review and meta-analysis of randomized-controlled trials. Europace 14:81–91, 2011.
Singh, J. P., H. U. Klein, D. T. Huang, S. Reek, M. Kuniss, A. Quesada, A. Barsheshet, D. Cannom, I. Goldenberg, S. McNitt, J. P. Daubert, W. Zareba, and A. J. Moss. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 123:1159–1166, 2011.
Sohail, M. R., D. Z. Uslan, A. H. Khan, P. A. Friedman, D. L. Hayes, W. R. Wilson, J. M. Steckelberg, S. M. Stoner, and L. M. Baddour. Risk factor analysis of permanent pacemaker infection. Clin. Infect. Dis. 45:166–173, 2007.
Spickler, J. W., N. S. Rasor, P. Kezdi, S. Misra, K. Robins, and C. LeBoeuf. Totally self-contained intracardiac pacemaker. J. Electrocardiol. 3:325–331, 1970.
Spragg, D. D., J. Dong, B. J. Fetics, R. Helm, J. E. Marine, A. Cheng, C. A. Henrikson, D. A. Kass, and R. D. Berger. Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathy. J. Am. Coll. Cardiol. 56:774–781, 2010.
Sterliński, M., A. Sokal, R. Lenarczyk, F. Van Heuverswyn, C. A. Rinaldi, M. Vanderheyden, V. Khalameizer, D. Francis, J. Heynens, and B. Stegemann. In heart failure patients with left bundle branch block single lead multispot left ventricular pacing does not improve acute hemodynamic response to conventional biventricular pacing. A multicenter prospective, interventional, non-randomized study. PLoS ONE 11:e0154024, 2016.
Stockburger, M., R. Bartels, L. Gerhardt, and C. Butter. Dual-site right atrial pacing increases left atrial appendage flow in patients with sick sinus syndrome and paroxysmal atrial fibrillation. Pacing Clin. Electrophysiol. 30:20–27, 2007.
Stockburger, M., S. Boveda, J. Moreno, A. Da Costa, R. Hatala, J. Brachmann, C. Butter, J. Garcia Seara, M. Rolando, and P. Defaye. Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in a general pacemaker population. Eur. Heart J. 36:151–157, 2014.
Sweeney, M. O., A. S. Hellkamp, K. A. Ellenbogen, A. J. Greenspon, R. A. Freedman, K. L. Lee, and G. A. Lamas. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937, 2003.
Swerdlow, C. D., S. Davie, R. M. Kass, P.-S. Chen, C. Hwang, W. J. Mandel, E. S. Gang, S. Raissi, and C. T. Peter. Optimal electrode configuration for pectoral transvenous intplantable defibrillator without an active can. Am. J. Cardiol. 76:370–374, 1995.
Thambo, J.-B., P. Bordachar, S. Garrigue, S. Lafitte, P. Sanders, S. Reuter, R. Girardot, D. Crepin, P. Reant, and R. Roudaut. Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation 110:3766–3772, 2004.
Thibault, B., M. Dubuc, P. Khairy, P. G. Guerra, L. Macle, L. Rivard, D. Roy, M. Talajic, E. Karst, and K. Ryu. Acute haemodynamic comparison of multisite and biventricular pacing with a quadripolar left ventricular lead. Europace 15:984–991, 2013.
Thébault, C., E. Donal, C. Meunier, R. Gervais, B. Gerritse, M. R. Gold, W. T. Abraham, C. Linde, J.-C. Daubert, and R. S. Group. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Eur. Heart J. 33:2662–2671, 2012.
Tjong, F., T. Brouwer, L. Smeding, K. Kooiman, J. de Groot, D. Ligon, R. Sanghera, M. Schalij, A. Wilde, and R. Knops. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance. Europace 18:1740, 2016.
Tomassoni, G., K. Newby, S. Deshpande, K. Axtell, J. Sra, M. Akhtar, and A. Natale. Defibrillation efficacy of commercially available biphasic impulses in humans importance of negative-phase peak voltage. Circulation 95:1822–1826, 1997.
Trayanova, N. A. Whole-heart modeling. Circ. Res. 108:113–128, 2011.
Udo, E. O., N. P. Zuithoff, N. M. van Hemel, C. C. de Cock, T. Hendriks, P. A. Doevendans, and K. G. Moons. Incidence and predictors of short-and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm 9:728–735, 2012.
van Gelder, B. M., M. G. Scheffer, A. Meijer, and F. A. Bracke. Transseptal endocardial left ventricular pacing: an alternative technique for coronary sinus lead placement in cardiac resynchronization therapy. Heart Rhythm 4:454–460, 2007.
van Rees, J. B., M. K. de Bie, J. Thijssen, C. J. W. Borleffs, M. J. Schalij, and L. van Erven. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. J. Am. Coll. Cardiol. 58:995–1000, 2011.
Verlato, R., G. L. Botto, R. Massa, C. Amellone, A. Perucca, M. G. Bongiorni, E. Bertaglia, V. Ziacchi, M. Piacenti, and A. Del Rosso. Efficacy of low interatrial septum and right atrial appendage pacing for prevention of permanent atrial fibrillation in patients with sinus node disease results from the electrophysiology-guided pacing site selection (EPASS) Study. Circ.: Arrhythmia Electrophysiol. 4:844–850, 2011.
Vijayaraman, P., M. K. Chung, G. Dandamudi, G. A. Upadhyay, K. Krishnan, G. Crossley, K. Bova Campbell, B. K. Lee, M. M. Refaat, S. Saksena, J. D. Fisher, and D. Lakkireddy. His bundle pacing. J. Am. Coll. Cardiol. 72:927–947, 2018.
Wathen, M. S., P. J. DeGroot, M. O. Sweeney, A. J. Stark, M. F. Otterness, W. O. Adkisson, R. C. Canby, K. Khalighi, C. Machado, and D. S. Rubenstein. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation 110:2591–2596, 2004.
Weizong, W., W. Zhongsu, Z. Yujiao, G. Mei, W. Jiangrong, Z. Yong, X. **nxing, and H. Yinglong. Effects of right ventricular nonapical pacing on cardiac function: a meta-analysis of randomized controlled trials. Pacing Clin. Electrophysiol. 36:1032–1051, 2013.
Yancy, Jr., C. W., and B. G. Firth. Congestive heart failure. Dis. Mon. 34:469–536, 1988.
Yartsev, A. Single and dual chamber pacing modes. In: Deranged Physiology. 2016. www.DerangedPhysiology.com.
Ypenburg, C., R. J. van Bommel, V. Delgado, S. A. Mollema, G. B. Bleeker, E. Boersma, M. J. Schalij, and J. J. Bax. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J. Am. Coll. Cardiol. 52:1402–1409, 2008.
Ypenburg, C., S. D. Roes, G. B. Bleeker, T. A. Kaandorp, A. de Roos, M. J. Schalij, E. E. van der Wall, and J. J. Bax. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am. J. Cardiol. 99:657–660, 2007.
Ypenburg, C., M. J. Schalij, G. B. Bleeker, P. Steendijk, E. Boersma, P. Dibbets-Schneider, M. P. Stokkel, E. E. van der Wall, and J. J. Bax. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur. Heart J. 28:33–41, 2006.
Zanon, F., E. Bacchiega, L. Rampin, S. Aggio, E. Baracca, G. Pastore, T. Marotta, G. Corbucci, L. Roncon, and D. Rubello. Direct His bundle pacing preserves coronary perfusion compared with right ventricular apical pacing: a prospective, cross-over mid-term study. Europace 10:580–587, 2008.
Zanon, F., E. Baracca, S. Aggio, G. Pastore, G. Boaretto, P. Cardano, T. Marotta, G. Rigatelli, M. Galasso, and M. Carraro. A feasible approach for direct his-bundle pacing using a new steerable catheter to facilitate precise lead placement. J. Cardiovasc. Electrophysiol. 17:29–33, 2006.
Zenati, M. A., G. Bonanomi, A. K. Chin, and D. Schwartzman. Left heart pacing lead implantation using subxiphoid videopericardioscopy. J. Cardiovasc. Electrophysiol. 14:949–953, 2003.
Zhuang, L., Y. Mao, L. Wu, W. Niu, and K. Chen. Effects of right ventricular septum or His-bundle pacing versus right ventricular apical pacing on cardiac function: a systematic review and meta-analysis of randomized controlled trials. J. Int. Med. Res. 46:3848–3860, 2018.
Acknowledgments
This work was funded by the European Union’s H2020: MSCA: ITN program for the “Wireless In-body Environment Communication—WiBEC” project under the Grant Agreement No. 675353.
Conflict of interest
Dr. Hans Henrik Odland reports personal fees from Abbot, grants from Medtronic, outside the submitted work. The other authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Peter E. McHugh oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Albatat, M., Bergsland, J., Arevalo, H. et al. Technological and Clinical Challenges in Lead Placement for Cardiac Rhythm Management Devices. Ann Biomed Eng 48, 26–46 (2020). https://doi.org/10.1007/s10439-019-02376-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-019-02376-0